CHONDRON has been safely tested and administered to more than 350 patients over last five years
Yash Sanghavi, MD & CEO and Satyen Sanghavi, CSO & ED, RMS Regrow elaborate on the potential of regenerative medicine and…
Author
Bliss GVS Pharma: Overcoming social bias
Bliss GVS Pharma has managed to break through the social bias against suppositories and pessaries in the Sub-Saharan African…
Zim Laboratories: On the growth path
Zim Laboratories' oral disintegrating strips is the latest offering of this Nagpur based company's NDDS portfolio by Usha Sharma
Pharmexcil is organising 12 buyer-seller meets this year
Recently appointed as Director General of the Pharmaceuticals Export Promotion Council (Pharmexcil), Uday Bhaskar's experience…
‘Over next three to five years, we intend to expand the existing capacities of large and small…
Amanta Healthcare, an Ahmedabad-based, mid-sized pharma company had introduced Steriport – a new generation concept of IV fluid…
‘We intend to continue our initiatives on innovation and greater manufacturing excellence’
The Indian medical device industry is currently going through a regulatory reform. Himanshu Baid, MD, Polymedicure, talks about…
‘Our next vaccine will be a three-dose rabies vaccine based on nano-particle technology’
Dr Rajiv Modi, CMD, CPL Biologicals, elaborates on the vaccines developed by his company, the huge positive impact they can have…
Pharmexcil seeks mfg cluster to counter Chinese imports
Pharma exports, which is currently pegged at $16.9 billion, is expected to grow at 10 per cent during the current year…
DRL posts Q2 FY17 and H1FY17 results
In Q2 FY17, EBITDA is at Rs 6.4 billion and profit after tax at Rs 2.9 billion
Purple Health A Platform For Innovation
DRL's endeavour seeks to institutionalise patient-centric thinking and design high quality interventions to address their needs in…